中国药物经济学
中國藥物經濟學
중국약물경제학
China Journal of Pharmaceutical Economics
2015年
10期
66-68
,共3页
心律失常%黄芪注射液%疗效%心肌酶谱
心律失常%黃芪註射液%療效%心肌酶譜
심률실상%황기주사액%료효%심기매보
Arrhythmia%Astragalus injection%Curative effect%Myocardial enzyme spectrum
目的:探讨黄芪注射液治疗心律失常患者的临床疗效。方法将190例严重心律失常患者按随机数字表法分为观察组和对照组,各95例。对照组患者给予常规抗心律失常、溶栓、降脂、抗凝、抗血小板聚集治疗,观察组患者在对照组治疗基础上加用黄芪注射液治疗。比较两组患者的治疗效果及心肌酶谱。结果观察组患者总有效率高于对照组,血清乳酸脱氢酶(LDH)、肌酸激酶(CK)、肌酸激酶同工酶(CK-MB)、天冬氨酸转氨酶(AST)均低于对照组(P<0.05)。结论在常规治疗基础上加用黄芪注射液治疗,可有效缓解心律失常患者的临床症状,改善心功能,提高临床治疗效果。
目的:探討黃芪註射液治療心律失常患者的臨床療效。方法將190例嚴重心律失常患者按隨機數字錶法分為觀察組和對照組,各95例。對照組患者給予常規抗心律失常、溶栓、降脂、抗凝、抗血小闆聚集治療,觀察組患者在對照組治療基礎上加用黃芪註射液治療。比較兩組患者的治療效果及心肌酶譜。結果觀察組患者總有效率高于對照組,血清乳痠脫氫酶(LDH)、肌痠激酶(CK)、肌痠激酶同工酶(CK-MB)、天鼕氨痠轉氨酶(AST)均低于對照組(P<0.05)。結論在常規治療基礎上加用黃芪註射液治療,可有效緩解心律失常患者的臨床癥狀,改善心功能,提高臨床治療效果。
목적:탐토황기주사액치료심률실상환자적림상료효。방법장190례엄중심률실상환자안수궤수자표법분위관찰조화대조조,각95례。대조조환자급여상규항심률실상、용전、강지、항응、항혈소판취집치료,관찰조환자재대조조치료기출상가용황기주사액치료。비교량조환자적치료효과급심기매보。결과관찰조환자총유효솔고우대조조,혈청유산탈경매(LDH)、기산격매(CK)、기산격매동공매(CK-MB)、천동안산전안매(AST)균저우대조조(P<0.05)。결론재상규치료기출상가용황기주사액치료,가유효완해심률실상환자적림상증상,개선심공능,제고림상치료효과。
Objective To investigate the clinical efficacy of astragalus injection treating arrhythmia patients.Methods 190 cases of severe arrhythmia patients were randomly divided into observation group and control group, 95 cases.In the control group were treated with conventional anti-arrhythmia,thrombolysis,lipid-lowering,antico- agulant,anti-platelet aggregation therapy was observed in patients astragalus injection therapy in the control group basis.Treatment and myocardial enzymes were compared indicators of the patient.Results Observation group were higher than the total efficiency,serum lactate dehydrogenase(LDH),creatine kinase(CK),creatine kinase(CK-MB), aspartate aminotransferase(AST)were low in the control group(P<0.05).Conclusions Based on conventional therapy plus astragalus treatment can effectively relieve symptoms of patients with arrhythmia,improve heart function, improve clinical outcomes..